OBJECTIVES: Postoperative acute exacerbation (PAE) of idiopathic pulmonary fibrosis (IPF) is a serious complication that is hard to treat. Therefore, it is important to manage IPF patients in such a way as to avoid PAE. Conversely, the relationship between postoperative acute lung injury and perioperative fluid administration has been reported. Herein, we analyse the perioperative risk factors of PAE of IPF, including fluid management.
INTRODUCTION
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial lung disease with a median survival of 2-5 years [1] . In addition, IPF is known to be associated with primary lung cancer. It has been reported that the incidence of primary lung cancer is increased in patients with IPF, ranging from 7.5 to 17.8%, and the effect is independent of the effect of cigarette smoking [2, 3] . Postoperative acute exacerbation (PAE) of IPF is associated with a high mortality rate after pulmonary resection; of all the postoperative complications, it is the most likely to be fatal [4] [5] [6] [7] . Although some authors have attempted to identify the predictors and the appropriate perioperative management for the prevention of PAE of IPF [4] [5] [6] [7] [8] , none have been established.
Conversely, fluid management is reported to be an important factor for acute lung injury (ALI) after thoracic surgery [9] [10] [11] . Therefore, we hypothesized that perioperative fluid balance was an important factor related to PAE of IPF, and reviewed the postoperative results of IPF patients with primary lung cancer at two institutions.
PATIENTS AND METHODS
From July 2004 to March 2011, the data of 1444 consecutive patients with primary lung cancer who underwent pulmonary resection at two institutions, Gifu University and Juntendo University School of Medicine, were retrospectively analysed. Of the 1444 patients, 62 (4.3%) had IPF clinically, and 52 of the 62 patients who underwent pulmonary resection excluding pneumonectomy and pulmonary wedge resection were assessed. The patients were diagnosed as having clinical IPF with American Thoracic Society (ATS)/European Respiratory Society (ERS) criteria for the diagnosis of IPF in the absence of a surgical lung biopsy [12] . This study was approved by the Gifu University and Juntendo University Institutional Review Boards for Clinical Research.
Preoperative evaluation, including a complete history, physical examination and laboratory findings (including arterial blood gas analysis, chest roentgenogram, electrocardiogram, pulmonary function tests and computed tomography (CT) of the chest and abdomen), was performed in all patients. Selected patients underwent an 18 F-fluorodeoxyglucose positron emission tomography, bronchoscopy, brain magnetic resonance imaging, echocardiogram, myocardial perfusion scintigraphy or coronary angiography for further assessment.
Before surgery, a thoracic epidural catheter was inserted routinely. After anaesthesia induction, patients were intubated using a double-lumen endotracheal tube for one-lung ventilation. The fraction of inspired oxygen during surgery was minimized by the anaesthesiologist, based on the intraoperative arterial blood gas analysis. In order to enter the thorax, a posterolateral or anterolateral thoracotomy with thoracoscopic assistance through a 7 to 25 cm long skin incision was performed. A hilar and mediastinal lymph node dissection was performed based on the progression of the lesion. In general, patients were extubated at the end of the operation and transferred to the intensive care unit or ward.
A prophylactic medication to prevent PAE of IPF was administered depending on the patient's condition and the decision of the doctor in charge. Chest radiographs were routinely taken on every postoperative day (POD). A chest CT was not performed routinely. Additional chest radiographs and CT were taken for further evaluation depending on the patient's clinical course rather than for all abnormal symptoms and signs. If infiltration was seen on the chest radiograph and CT, patients were diagnosed as having PAE of IPF, based on the following criteria [13] : (i) aggravation of dyspnoea; (ii) hypoxaemia with an arterial oxygen tension/inspired oxygen tension ratio of <225; (iii) newly developing pulmonary infiltrates on chest radiography and (iv) the absence of apparent infection or heart disease. Especially, the differential diagnosis between PAE of IPF and postoperative infection is important. Upon the occurrence of the abnormal shadow on a chest X-ray and CT, we performed the tests for the infectious diseases, e.g. white blood cell count, C-reactive protein (CRP), procalcitonin, D-beta-glucan, Aspergillus antigen, Candida antigen, cytomegalovirus pp65 antigenaemia, Pneumocystis carinii DNA, sputum culture and blood culture. We consulted respiratory physicians and radiologists about the clinical and radiographic diagnosis. Moreover, we administered broad-spectrum antibiotics. Under the consideration of the results of the tests and reaction of antibiotics, we denied postoperative infection.
The inhalation dosage of postoperative oxygen was minimized to maintain SpO 2 at 92% or greater, and to maintain the patient's physical condition.
When PAE of IPF developed, a steroid pulse therapy with methylprednisolone was given as the first-line treatment. If the steroid pulse therapy was not effective, a second-line treatment was given, which included an immunosuppressive drug and/or a polymyxin B-immobilized fibre column haemoperfusion treatment.
We assessed all resected specimens regardless of whether the patients had usual interstitial pneumonia (UIP), with histological findings. In this series, we excluded the patients diagnosed as having other diffuse parenchymal lung diseases, e.g. emphysema, chronic obstructive lung disease, non-specific interstitial pneumonia, bronchitis and sarcoidosis. However, if the resected specimens did not include the area of fibrosis or honeycombing, especially the tumour located in the upper lobe, they could not provide the confidential pathological findings for UIP/IPF. Therefore, we included the patients who could be diagnosed as having clinical IPF, according to the ATS/ERS criteria.
For comparisons between the two groups, PAE of IPF(−) and PAE of IPF(+), statistical evaluation was performed using IBM SPSS Statistics 18 software (SPSS, Chicago, IL, USA). Differences in categorical values were tested by χ 2 test (or Fisher's exact test). Continuous values were tested by an unpaired Student's t-test. A Mann-Whitney U-test was used to compare nonnormally distributed data. A multivariate analysis was performed using a logistic regression test. All the values with P < 0.10 at the univariate analysis were entered in a multivariate analysis. P < 0.05 was considered as significant.
RESULTS
Of the 52 patients, seven (13.5%) developed PAE of IPF, which occurred from the 2nd to the 13th day (median, 6th day) after surgery. The mortality rate of PAE of IPF was 85.7%; all deaths were caused by severe respiratory failure induced by uncontrollable PAE of IPF. Only one patient recovered in response to the steroid pulse therapy.
As detailed in Table 1 , the patient characteristics of the two groups were similar; there were no significant differences, except for the preoperative CRP levels. Similarly, there were no significant differences in the arterial blood gas and pulmonary function test values, including percentage diffusion capacity for carbon monoxide (DLCO), between the two groups. Five kinds of prophylactic medications (nafamostat mesilate, hydrocortisone, sivelestat sodium hydrate, sivelestat sodium hydrate + methylprednisolone and methylprednisolone) to prevent PAE of IPF were given. No significant difference in these medical treatments was seen between the groups.
The intraoperative and postoperative findings are listed in Table 2 . Upon univariate analysis, the amount of intraoperative fluid infused (7.71 ± 3.11 versus 10.3 ± 3.66 ml/kg/h, P = 0.049) and the intraoperative fluid balance (4.99 ± 2.86 versus 8.00 ± 4.21 ml/kg/h, P = 0.035) were significantly greater in patients who developed PAE of IPF than in those who did not. Body weight change, defined as the maximum body weight gain from the preoperative day to the discharge day or the onset day of PAE of IPF, and body weight change up to POD 1, defined as the body weight change from the preoperative day to POD 1, were not significantly different between the two groups. There were also no significant differences in the oncological factors (tumour size, histology, tumour location and pathological stage) or in the occurrence of postoperative complications. Regarding the postoperative complications, prolonged air leak, mild pneumonia (all cases were cured with antibiotics), chylothorax, gastric ulcer, atrial fibrillation, the elevation of transaminase and aggravation of the chronic rheumatoid arthritis symptom were shown.
As shown in Table 3 , the multivariate logistic regression analysis showed that intraoperative fluid balance and CRP were the predictive factors for the postoperative PAE of IPF [P = 0.026, odds ratio (OR) = 1.312 and P = 0.048, OR = 1.280, respectively].
DISCUSSION
As a result of recent advances in preoperative evaluation, surgical techniques, anaesthesia and postoperative care, the mortality after surgery for lung cancer has been kept very low (30-day mortality, 0.4%) in Japan [14] . In this report, of the 237 deaths after pulmonary resection for lung cancer, 63 were caused by PAE of IPF [14] . Therefore, IPF is one of the most important risk factors for morbidity and mortality after pulmonary resection. Currently, surgery has been established as the primary treatment for lung cancer. Even in patients with IPF, the long-term efficacy of surgical treatment for lung cancer has been reported [5, 15, 16] . In the cases of chemotherapy and radiation therapy for lung cancer with IPF, the incidence of treatment-related PAE of IPF was reported to range from 5.6 to 21% [17] and around 25% [18] , respectively. Conversely, the incidence of surgery-related PAE of IPF was reported to range from 7.1 to 20% [4] [5] [6] [7] ; therefore, surgery cannot be avoided without a thought, if there is radicality for lung cancer. However, because of the high mortality rate (75-100%) of PAE of IPF when it occurs [4] [5] [6] [7] , it is important to prevent PAE of IPF. Some authors have reported the predictive factors for the development of PAE of IPF. Exertional dyspnoea, CRP, lactate dehydrogenase (LDH), restrictive ventilatory impairment, percent DLCO, tumour histology and KL-6 have been reported as predictive factors [4, 6, 7] . In the present study, patient characteristics, pulmonary function test results, oncological characteristics and laboratory findings other than CRP did not show any significant differences between the patients who did and did not develop PAE of IPF. Some reports [4, 5, 8] suggested that the incidence of PAE of IPF correlated with the extent of the pulmonary resection. The results of the present study showed that patients with larger pulmonary resections (lobectomy and bilobectomy) had a higher incidence of postoperative exacerbations, albeit non-significantly. The one patient who underwent pneumonectomy and the nine who underwent wedge resections were excluded from this study. Some authors reported a high incidence of postoperative ALI occuring in patients who underwent pneumonectomy [11] . Because pneumonectomy itself is considered to be a risk factor, we excluded the patient with pneumonectomy. Conversely, the patients who underwent wedge resections were excluded because we considered that wedge resections had less influence on intrapulmonary circulation for the following reasons: (i) The pulmonary vascular bed hardly decreases.
(ii) There is no injury of the lymphatic systems. Regarding the intraoperative blood loss, although statistical significance was not detected, the amount of blood loss tended to be more in patients who developed PAE of IPF. The blood loss and consequently the required higher intraoperative fluid administration, together, could support at least an adverse tendency of PAE of IPF. On the other hand, since excessive fluid infusion has been reported to be one of the risk factors for ALI after thoracic surgery for lung cancer [9, 10] , we analysed fluid management to determine whether it could be a risk factor for PAE of IPF. Licker et al. [9] identified fluid infusion during anaesthesia as one of the risk factors for the development of primary ALI after lung resection. The patients who did and did not develop ALI received 9.1 and 7.2 ml/kg/h of intraoperative fluid infusion, respectively [9] . In the present study, patients who did and did not develop PAE of IPF received 10.3 and 7.71 ml/kg/h fluid infused, respectively. Thus, 7-8 ml/kg/h is considered as the proper amount of intraoperative fluid infusion for patients undergoing pulmonary resection. Moreover, because intraoperative fluid balance is more important, as revealed in the present study, it is desirable that it be restricted to within 5 ml/kg/h, considering urinary excretion and blood loss. With respect to water balance during surgery, Okamoto et al. [6] reported no significant difference between patients who did and did not develop PAE of IPF. Because they compared the two groups simply on the basis of water balance (ml), a different result could have been obtained had they analysed the value corrected for the patient's weight and operation time. With respect to the assessment of postoperative fluid management, weight gain from the preoperative state was analysed in the present study. Because the patients usually had meals from POD 1, fluid balance could not be assessed using the amount of fluid infused. Though changes in body weight both throughout the clinical course and up to POD 1 showed no significant differences between the two groups, the patients who developed PAE of IPF tended to gain weight postoperatively.
With respect to the prophylactic medication to prevent PAE of IPF, there is no definitive evidence. Even corticosteroid therapy, which has been analysed most frequently, has been controversial [13, 16] . In the present study, there was no significant difference among the five kinds of regimens used. To establish the most appropriate prophylactic treatment, prospective, controlled trials are required.
In the present study, a thoracotomy was performed with thoracoscopic assistance and a 7 to 25 cm long skin incision to approach the lung. Koizumi et al. [4] and Akiba et al. [19] described the effectiveness of the video-assisted thoracic surgery approach. However, compared with our data, operation time and blood loss were greater in both reports [4, 6] . Despite there being no significant difference between the two groups in terms of operation time and blood loss, we consider that a short operation time and low blood loss are preferable, and we adopted a posterolateral or anterolateral thoracotomy with thoracoscopic assistance and a minimal skin incision as the appropriate approach.
STUDY LIMITATIONS
A retrospective analysis is susceptible to various factors of bias, which could not have been identified and controlled. In the present study, we could not analyse the data of ventilatory management of one-lung ventilation. We recognize that the values of a fraction of inhalation oxygen (FiO 2 ) and tidal volume (TV), which were reported as the predictors of post-thoracotomy ALI [20] , may be important factors for PAE of IPF. Therefore, we managed the FiO 2 and TV as low as possible to maintain SpO 2 >90% during operation. Because the value of FiO 2 and TV were various, we could not collect suitable data.
Another limitation is that we could not present the haemodynamic parameters. Diaper et al. [21] reported the benefit of transoesophageal Doppler monitoring (TDM) during the intraoperative period for restrictive fluid strategy for undergoing lung cancer resection. To decide the favourable amount of fluid infusion during the intraoperative and postoperative period, further examination is needed. The haemodynamic parameters shown by intraoperative TDM or postoperative transthoracic echocardiogram are considered to be helpful for a detailed analysis.
Because of the small sample size of this study, we may have indicated an accidental relationship between the amount of intraoperative fluid infused and PAE of IPF. Therefore, a randomized control study that minimizes the patient bias, including the preoperative prophylactic medication and the intraoperative value of a FiO 2 , TV, one-lung ventilation time, lateral position time and other hidden factors, is needed.
CONCLUSIONS
This study is the first to demonstrate the importance of fluid management for the prevention of PAE of IPF. Although further study is needed, intraoperative fluid infusion should be minimized for patients, especially those with IPF and an inflammatory reaction before surgery, who undergo pulmonary resection.
